SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is experiencing heightened volatility and market manipulation concerns as investors react to a rambling press conference by Donald Trump regarding the ongoing Iran conflict. Traders are actively debating whether the lack of concrete ceasefire details, paired with aggressive rhetoric and continued oil price increases, signals a massive upcoming sell-off or a rigged rally designed to burn options premiums.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing downward pressure following a harsh analyst downgrade that cited poor Q1 delivery figures and concerns over the company's valuation relative to its EV sales. Investors are actively debating whether to buy the dip or exit positions, with many discussing the potential for a rotation into the upcoming SpaceX IPO.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently experiencing significant downward pressure, with shares recently hitting fresh all-time lows amid ongoing frustration regarding manufacturing scale-up delays and missed quarterly milestones. While the community remains polarized, with some bulls pointing to a significant cash position and potential upside from future customer purchase orders, many traders are vocal about the lack of consistent execution and are actively discussing the possibility of further price declines toward the mid-four-dollar range.

Invesco QQQ Trust Series 1 - Units of beneficial interest

Invesco QQQ Trust is experiencing heavy volatility as investors weigh conflicting reports of ceasefire negotiations against ongoing military tensions in the Middle East, leading to intense debate among market participants about whether current price action reflects genuine growth or orchestrated market manipulation. The community is actively parsing news regarding geopolitical deadlines and oil price shifts while attempting to navigate algorithmic swings driven by uncertainty.

Tower Semiconductor Ltd. engages in providing semiconductor solutions. It also offers technology and manufacturing platforms for integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, mobile, infrastructure, medical, and aerospace and defense. It focuses on creating positive and sustainable impact on the world through long term partnerships and its advanced and innovative analog technology offering, comprised of a broad range of customizable process platforms such as SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, non-imaging sensors, integrated power management (BCD and 700V), and MEMS. Its designs enable a quick and accurate design cycle as well as process transfer services including development, transfer, and optimization, to IDMs and fabless companies. The company was founded in 1993 and is headquartered in Migdal Haemek, Israel.

Tower Semiconductor Ltd.

Tower Semiconductor is currently trending following news of a new U.S. foundry agreement with Intel that utilizes New Mexico capacity to support demand for analog processing. Investors are actively discussing the company's standalone growth prospects and the operational shift following the termination of previous acquisition plans.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as the community anticipates massive contract announcements and long-term order growth fueled by the company's critical role in testing AI semiconductor infrastructure. Traders are intensely focused on high-volume activity and signs of institutional accumulation, viewing the stock as a key bottleneck play in the broader AI data center and silicon photonics expansion.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune Company Limited ($MGRT) is trending as retail traders monitor its volatile price action and frequent trading halts, often comparing its movement to other low-float Chinese IPOs. The community remains deeply divided, with some betting on a potential squeeze and parabolic gains, while many others warn of a typical 'pump and dump' scam that frequently characterizes similar recent market entrants.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as the community debates the geopolitical volatility surrounding the escalating conflict with Iran, highlighted by threats to regional energy infrastructure and ongoing tensions over the Strait of Hormuz. Investors and political commentators remain sharply divided, with discussions centered on the potential market impact of these developments, skepticism toward official press briefings, and the broader implications for the U.S. domestic economy and national security.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense volatility and aggressive trading as investors debate whether recent price action is a fundamental valuation correction driven by AI-related substrate demand or a speculative bubble prone to a sharp reversal. The community remains deeply divided, with many traders monitoring for a potential dilution event while others emphasize the company's critical role in the photonics supply chain.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

The $FUST token is gaining momentum as the community focuses on its utility within the $FUSD ecosystem, specifically highlighting an upcoming NFT platform launch and ongoing passive income rewards. Investors are actively discussing the project's long-term structure and its goal of offering an appreciating alternative to traditional stablecoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS - Aza approved years ago, on Generic Pricing, Ven 2017 approval - window closing - Current Pricing for the Last 3 AML Approved Drugs  
- Do the MATH - Buy SLS, your future YOU will thank you.   
- &quot;The Kura Q4 earnings call characterized Revuforj&#39;s annual WAC as &quot;almost $1 million a year&quot; due to its dosing schema and SKU structure&quot;  
 
- &quot;The menin inhibitor pricing gap (~$600K vs. ~$1M annually) has already become a payer access flashpoint, with at least some plans beginning to implement step edits favoring ziftomenib first.&quot;  
  
-- Events are NOT Linear this far along in a OS trial for AML Cr2 Patients, who are Ineligible for Transplant - with inherent co-morbidities and the 2 to 5 year time in trial for those remaining alive, mean we could see Events in Spates and the Top Line Results ANY DAY NOW.  https://www.reddit.com/r/sellasLifescience/comments/1sdpysk/events_are_not_linear_this_far_along_in_a_os/?share_id=vDnR6Nqf6rYL2WJS5gHiE&amp;utm_content=2&amp;utm_medium=ios_app&amp;utm_name=ioscss&amp;utm_source=share&amp;utm_term=1

Tony M

William

Green_Dream

Frog Prince

Jeremy Dworkin

5,500% ROI this quarter

Bradley Johnson

Benjamin

CMSP

reddit

Events are NOT Linear this far along in a OS trial for AML Cr2 Patients, who are Ineligible for Transplant - with inherent co-morbidities and the 2 to 5 year time in trial for those remaining alive, mean we could see Events in Spates and the Top Line R...

$SLS 80K AML patients diagnosed each year - globally - remission rates exceed 80%. 
- 56K obtain a first remission - the Viale-M $ABBV setting. 
+40,000 will benefit from Gps Immunotherapy - Mskcc Phase 2 MOS greater than 67.6 Months Not reached which is better than transplant and current SOC 28-35months. 
- GPS PHASE 3 Approval for CR2, requires the entire Market add / include this CR1 patient setting to SLS’ Value. 
40,000 with $280K per patient Y1 rev 
Y 2 + and up to 5 years - at $110K  
- DO THE MATH - and you’ll see why this $0.73B manipulated equity will 10X and still have 2 Doubles in it for Vanguard and Blackrock.

StockTwits Web

SELLAS Life Sciences Group Inc

Abbvie Inc

 - Aza approved years ago, on Generic Pricing, Ven 2017 approval - window closing - Current Pricing for the Last 3 AML Approved Drugs  
- Do the MATH - Buy SLS, your future YOU will thank you.   
- "The Kura Q4 earnings call characterized Revuforj's annual WAC as "almost $1 million a year" due to its dosing schema and SKU structure"  
 
- "The menin inhibitor pricing gap (~$600K vs. ~$1M annually) has already become a payer access flashpoint, with at least some plans beginning to implement step edits favoring ziftomenib first."  
  
-- Events are NOT Linear this far along in a OS trial for AML Cr2 Patients, who are Ineligible for Transplant - with inherent co-morbidities and the 2 to 5 year time in trial for those remaining alive, mean we could see Events in Spates and the Top Line Results ANY DAY NOW.  